DOCSLIB.ORG

Igd Myeloma: Immunology and Ultrastructure

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Igd Myeloma: Immunology and Ultrastructure ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 8, No. 3 Copyright © 1978, Institute for Clinical Science IgD Myeloma: Immunology and Ultrastructure NOEMI-JEANA IOACHIM, M.D., PATRICK J. McKENNA, M.D., IRA HALPERIN, M.D., and FREDERICK J. CHUNG St. Vincent’s Hospital and Medical Center, New York, NY 10011 ABSTRACT A case of multiple myeloma producing IgD-M component with light chains of lambda type is reported. It involved the skeleton and was compli­ cated by compression of the spinal cord and massive extension to the pleura. The urine contained lambda Bence Jones protein. Under the electron micro­ scope, the neoplastic plasma cells showed dissociation between nuclear and cytoplasmic maturation. Introduction covered, only 145 cases were re­ ported.11,13,14,20,26 An additional case, with In 1965, Rowe and Fahey demonstrated immunologic and electron microscopic IgD, a new class of human immunoglob­ studies is presented here. ulins, in the serum of a patient with multi­ ple myeloma.23 Subsequently, the same investigators demonstrated the existence Case History of minute amounts of IgD in the normal A 65 year old white male was admitted to St. Vin­ serum.24 cent’s Hospital in July, 1974 with a three week history of pleuritic chest pain and thorocolumbar back pain. Of all lymphocytes with surface In addition, he had a six month history of frequency, immunoglobulins, about 18 percent have nocturia, constipation and a 22 kgms weight loss. membrane-bound IgD27 in contrast to the Physical examination revealed a cachectic white male in no acute distress. The only abnormalities small amounts of IgD in the serum. How­ noted were dullness to percussion and decreased ever, while membrane-associated IgD in­ breath sounds posteriorly over the left hemithorax. cludes mainly kappa light chains, the light Hemoglobin was 13.7 g per dl, hematocrit was 41 percent, WBC was 5,300 per mm3 with a normal chain component of normal serum IgD is differential count. BUN, creatinine, uric acid, cal­ of lambda type.21 The biologic activity of cium, phosphorus and alkaline phosphatase were IgD immunoglobulins is suggested by within normal limits. Roentgenographic examination of the chest showed a left pleural mass and complete their association with various pathologic destruction of the left rib, posteriorly. A skeletal sur­ entities including immune complex vey showed osteolytic lesions of the skull, left hu­ glomerulonephritis,15 systemic lupus meral head, fifth and sixth thoracic vertebrae and a large thoracic paravertebral mass. Biopsy of the latter erythematosus,30 chronic lymphocytic showed tumor tissue composed of immature plasma leukemia and Burkitt’s lymphoma.1,16 cells. A posterior iliac crest bone marrow aspiration Plasma cell myelomas with an IgD and biopsy similarly showed extensive infiltration with immature plasma cells. M-component are very rare. To date, 12 The patient was treated with melphalan, predni­ years after this pathologic entity was dis­ sone and procarbazine given intermittently at six 209 0091-7370/78/0500-0209 $01.50 © Institute for Clinical Science, Inc. 2 1 0 IOACHIM, MCKENNA, HALPERIN AND CHUNG weeks intervals for seven consecutive days. After the line on immunoelectrophoresis de­ first month of treatment, there was relief of pain, a veloped with IgD heavy chain and lambda decrease in the size of the thoracic mass and a de­ crease in the serum monoclonal protein. light chain antisera (figure 1). Electro­ In October 1974, the patient developed paraplegia phoresis of concentrated urine showed a after collapse of the fifth and sixth thoracic vertebrae. spike with beta mobility. Immunoelectro­ He was operated upon successfully; however, in the following months progressive renal failure de­ phoresis showed this to be lambda light veloped and the patient died in February 1975. chains (figure 2). Methods L i g h t M ic r o s c o p y P r o t e in S t u d ie s Sections of a pleural biopsy in the area of the fifth rib showed portions of markedly Serum and urine protein electro­ thickened pleura infiltrated by neoplastic phoresis was performed on cellulose ace­ plasma cells (figure 3). tate membranes with barbital buffer pH A bone marrow biopsy showed bony 8.6, ionic strength 0.05M. trabeculae and densely hypercellular Immunoelectrophoresis was performed bone marrow. The latter contained few on 0.9 percent agarose plates with the same residual lobules of adipose tissue and mas­ buffer as described and developed with ses of neoplastic plasma cells. Some were specific antisera to IgG, IgA, IgM, IgD, of mature type while others were abnor­ IgE, and kappa and lambda light chains.* mally large with irregularly-shaped nucle i Immunoglobulins were quantitated by ra­ and some were binucleated. Mitoses dial immunodiffusion.9 Cryoglobulins and were often present. Sia test were determined by standard methods. Serum viscosity was measured E l e c t r o n M ic r o s c o p y with a microcone plate viscosimeter.f Sections of the pleural mass showed E l e c t r o n M ic r o s c o p ic St u d ie s closely packed plasma cells of various sizes and phases of maturation. The cyto­ Tissues were fixed in 2 percent glu- plasm was fairly abundant and almost en­ teraldehyde in phosphate buffer pH 7.2 for tirely filled by the endoplasmic reticulum. two hours at 4° C. After washingin sucrose, The latter was well-developed with mark­ the tissues were post-fixed in osmium edly dilated cisternae and studded with tetraoxide for one hour. Following dehy­ ribosomes (figure 4). dration and embedding in Epon 812, thin The cytoplasm also included a Golgi sections were cut with an LKB microtome, complex and numerous electron dense in­ stained with uranyl acetate and lead citrate clusion bodies which sometimes and examined with an RCAEMU-3Gelec- coalesced resulting in bizarre shapes. On tron microscope. occasion, the whole cytoplasm was filled with inclusions displacing the nucleus to Results the periphery of the cell which appeared I m m u n o l o g ic St u d ie s degenerated. The nucleus was generally large with coarse, irregular clumps of Total proteins varied between 5.0 to 6.5 heterochromatin. In contrast to normal g per dl. Serum protein electrophoresis, plasma cells in which nucleoli are inappa- serum viscosity, IgG, IgA and IgM were rent, myeloma cells had one or two promi­ normal. The Sia test and the test for cryo­ nent nucleoli usually spherical and con­ globulins were negative. IgD was 65 mg densed (figure 5). Some of the nucleoli per dl. There was an abnormal precipitin were ring-shaped with coarse granules of * Hyland. chromatin-like material in their center. f Brookfield. Mitotic division of the nucleus was noted IGD MYELOMA: IMMUNOLOGY AND ULTRASTRUCTURE 2 1 1 D F ig u re 1. Serum immunoelectrophoresis showing an M-compo- nent with IgD lambda identity. K L V'1 NORMAL SERA ANS G F ig u r e 2. Urine immunoelectrophoresis showing lambda Bence Jones protein. D K 2 1 2 IOACHIM, MCKENNA, HALPER1N AND CHUNG Figure 3. Tumor mass involving pleura. Neo­ plastic plasma cells with markedly pleomorphic nuclei replace fibroadi- pose tissues (Formalin fixation, H&E x 400). in cells with well-differentiated cytoplasm homogeneous protein are needed to pro­ (figure 6). Binucleated cells were fre­ duce a spike on serum protein electro­ quent. Based on the general electron mi­ phoresis,31 an IgD M-component must in­ croscopic appearance of the cell matrix, crease 100 times its value before it be­ light and dark forms of myelomacells were comes detectable by the usual screening noted (figure 7). procedures. Similar to this patient who, at admis sion time, did not s ho w a monoclonal Discussion peak on protein electrophoresis, many IgD myeloma is an uncommon disease. cases of IgD myeloma display a modest About three percent of all myelomas are of monoclonal peak or no peak at all and are the IgD class.8,10,12,13,14 In the authors’ possibly missed although they could al­ hospital, of 87 cases of multiple myeloma ways be detected by immunoelectro- examined between 1970 and 1977, only phoresis. one was of the IgD type (table I). As protein abnormalities of multiple Since the normal concentration of IgD in myeloma are studied in more detail, cer­ the serum is 3 mg per dl and300 mg per dl of tain discrete clinical patterns are often IGD MYELOMA: IMMUNOLOGY AND ULTRASTRUCTURE 213 FIGURE 4. Cluster of tumor cells showing cytoplasm with numerous mitochondria (M), abundant vesicular endoplasmic reticulum (ER), and large nuclei (N) with clumped chromatin and prominent nucleoli (Uranyl acetate and lead citrate x 5800). found with particular classes, sub-classes hypercalcemia occurs in IgG3 myeloma,7 or light chain types of immunoglobulins. coagulation disorders are associated with Thus, hyperviscosity is most frequent in IgA myeloma28 and lambda light chain dis­ macroglobulinemia and IgG3 myeloma,29 ease shows a higher incidence of renal 214 IOACHIM, MCKENNA, HALPERIN AND CHUNG F ig u r e 5. Neoplastic-plasma cell with irregularly-shaped nucleus (N), including two large compact nucleoli lacking pars amorpha. Well-developed endoplasmic reticulum (ER), mitochondria (M) and Golgia area (G). Uranyl acetate and lead citrate x 8000. failure.2 IgD myeloma appears in a tient.3,12 On occasion,10 expanding tumor younger age group, includes more often masses in the spine have compressed the extraskeletal tumors and has a shorter sur­ spinal cord resulting in a variety of vival time. The median age at diagnosis is neurological signs. Although the neoplas­ 56 years with a range from 27 to 86 tic plasma cells usually infiltrate and re­ years.13,14 In a review of 133 cases by Jan- place large areas of hematopoetic bone celewicz et al,14 men outnumber women marrow, they are not released in the three to one, a difference not observed for peripheral blood and only a few cases of other types of myeloma.
Load more

Recommended publications
  • Cytology of Myeloma Cells
    J Clin Pathol: first published as 10.1136/jcp.29.10.916 on 1 October 1976. Downloaded from J. clin. Path., 1976, 29, 916-922 Cytology of myeloma cells F. G. J. HAYHOE AND ZOFIA NEUMAN1 From the Department of Haematological Medicine, Cambridge University SYNOPSIS A cytological, cytochemical, and cytometric study of plasma cells from 195 cases of multiple myeloma showed that, contrary to earlier reports, flaming cells, thesaurocytes, and intra- nuclear inclusions are not confined to IgA-secreting cases but are common also in IgG and Bence Jones varieties of myeloma. IgA-secreting cells are not larger, nor do they have a lower nuclear- cytoplasmic ratio than other myeloma cells. On average, for a given mass of tumour, Bence-Jones, IgG, and IgA varieties of myeloma produce amounts of paraprotein in the ratio 1 to 1 6 to 2-7. In 1961 Paraskevas et al reported a correlation the results of a larger scale survey carried out some between the morphological features of plasma cells years ago but previously unpublished. in myeloma and the type of immunoglobulin secreted. The cases studied included 12 with y1A Material and methods (f2A, IgA) myeloma, 30 with y (IgG) myeloma, and six myelomas without M protein (probably Bence The study was performed on bone marrow smearscopyright. Jones myelomas). Flaming cells, thesaurocytes, and from 200 consecutive patients newly entered into a intranuclear, PAS-positive inclusion bodies were comparative trial of treatments in myeloma, under found only in cases of IgA myeloma, and flaming the auspices of the Medical Research Council. Five cells especially were present in most cases and in patients were subsequently excluded as not confirmed high percentage in several.
    [Show full text]
  • Evidence-Based Practice Center Systematic Review Protocol
    Evidence-based Practice Center Systematic Review Protocol Project Title: Serum-Free Light Chain Analysis for the Diagnosis, Management, and Prognosis of Plasma Cell Dyscrasias I. Background and Objectives for the Systematic Review Plasma cell dyscrasias (PCDs) are a spectrum of disorders characterized by the expansion of a population of monoclonal bone-marrow plasma cells that produce monoclonal immunoglobulins.1 At the benign end of the spectrum is monoclonal gammopathy of undetermined significance (MGUS), where the plasma-cell clone usually does not expand. Multiple myeloma (MM) is a plasma cell disorder at the malignant end of the spectrum and is characterized by the neoplastic proliferation of a clone of plasma cells in the bone marrow with resulting end-organ damage, including skeletal destruction (lytic bone lesions), hypercalcemia, anemia, and renal insufficiency. Whereas monoclonal plasma cells generally secrete intact immunoglobulin, in about 20 percent of patients with MM these cells only produce light-chain monoclonal proteins (i.e., light-chain multiple myeloma [LCMM], formerly known as Bence Jones myeloma) and in 3 percent of patients they secrete neither light- nor heavy-chain monoclonal proteins that are detectable by immunofixation (i.e., nonsecretory multiple myeloma [NSMM]).1 In two-thirds of patients with NSMM, a monoclonal protein can be identified by the serum-free light chain (SFLC) assay. Patients with LCMM develop complications related to tissue deposition of light chains, including amyloidosis. Amyloid light-chain (AL) amyloidosis is the most common form of systemic amyloidosis seen in the United States and is characterized by a relatively stable, slow-growing plasma-cell clone that secretes light-chain proteins that form Table 1: Diagnostic criteria and clinical course of selected plasma cell dyscrasias (PCDs)2 Disorder Disease Definition Clinical Course Monoclonal gammopathy of .
    [Show full text]
  • Canine Multiple Myeloma
    Canine Multiple Myeloma Meredith Maczuzak, DVM; Kenneth S. Latimer, DVM, PhD; Paula M. Krimer, DVM, DVSc; and Perry J. Bain, DVM, PhD Class of 2003 (Maczuzak) and Department of Pathology (Latimer, Krimer, Bain), College of Veterinary Medicine, University of Georgia, Athens, GA 30602-7388 Introduction Multiple myeloma or plasma cell myeloma, is a neoplasm of well- differentiated B cell lymphocytes typically originating from the bone marrow. Neoplastic cells can metastasize widely, having a predilection for bone and resulting in osteolysis. The malignant transformation of a single B cell can secrete a homogenous immunoglobulin product known as paraprotein, which will mimic the structure of normal immunoglobulins. Overabundant production of paraprotein, consisting of any of the immunoglobulin classes, will appear as a sharp, well-defined peak or monoclonal gammopathy on serum electrophoresis. The most frequently encountered multiple myelomas secrete IgG or IgA paraproteins, however IgM myelomas (macroglobulinemia) have also been diagnosed in companion animals. Light chain disease is caused by plasma cell overproduction of the light chain segment of the immunoglobulin complex, consisting of either the lambda or kappa light chain. These proteins are referred to as Bence-Jones proteins and are the most commonly observed immunoglobulin fragments in the monoclonal gammopathies.2 There are rare instances where a malignant plasma cell neoplasm will be nonsecretory. These tumors occur in approximately 1% of all cases of multiple myeloma and are referred
    [Show full text]
  • Chapter 7: Hematologic Disorders and Kidney Disease
    Chapter 7: Hematologic Disorders and Kidney Disease Ala Abudayyeh, MD,* and Kevin Finkel, MD, FACP, FASN, FCCM*† *Division of General Internal Medicine, Section of Nephrology, University of Texas MD Anderson Cancer Center, Houston, Texas; and †UTHealth Science Center at Houston Medical School, Department of Medicine, Division of Renal Diseases and Hypertension, Houston, Texas MULIPLE MYELOMA chains precipitate with Tamm-Horsfall protein (THP) secreted by the thick ascending limb of the Pathogenesis loop of Henle and produce casts in the distal tubule. Multiple myeloma (MM) is a hematologic malig- Decreased GFR may increase the concentration of nancy involving the pathologic proliferation of light chains in the distal tubule and enhance the terminally differentiated plasma cells. It is the formation of casts. Therefore, hypercalcemia, vol- second most common hematologic malignancy ume depletion, diuretics, and nonsteroidal anti- behind non-Hodgkin lymphoma, with an annual inflammatory drugs can exacerbate renal injury. incidence of 4–7 cases per 100,000 in the United In some cases of AKI associated with MM, cast States. Clinical symptoms are due to osteolysis of formation is rare on renal biopsy. Instead, renal the bone, suppression of normal hematopoiesis, injury is attributed to the direct toxic effects of and the overproduction of monoclonal immuno- urinary free light chains (FLCs) on proximal tubule globulins that deposit in organ tissues. Clinical cells (5,6). After reabsorption, lysosomal degrada- symptoms include bone pain and fractures, anemia, tion of FLCs can activate the NF-kB pathway lead- infections, hypercalcemia, edema, heart failure, and ing to oxidative stress with an inflammatory renal disease. response, apoptosis, and fibrosis.
    [Show full text]
  • Intranuclear Inclusions in Myeloma Patient
    Published online: 2021-05-24 Letter to Editor Pathologist’s Feast: Intranuclear Inclusions in Myeloma Patient Sir, aspiration [Figure 2]. Plasma cells showed Dutcher body We present a case of a 36‑year‑old female admitted in bone marrow aspiration [Figure 3] as periodic acid– in hospital with complaints of pain in sacral region Schiff positive intranuclear inclusion [Figure 4]. The bone radiating toward right lower limb for 1 month. Laboratory marrow biopsy showed loss of normal architecture with examination revealed hemoglobin 8.1 g/dL, red blood packed marrow studded by plasma cells [Figure 5]. cell count – 2.61 × 109/mm3, white blood cell count Multiple myeloma account for 1% of all cancers and 16.16 × 103/mm3, and platelet count 299 × 109/mm3. The approximately 10% of all hematological malignancies.[1] The differential showed polymorphs – 74%, lymphocytes – 22%, eosinophils – 1%, and monocytes – 3%. Peripheral blood peak incidence is seventh decade, and it is quite rare, below smear showed rouleaux formation in red blood cells. The 40 years of age. The clinical and biological characteristics serum biochemistry showed blood urea – 54 mg/dl and of multiple myeloma in young patients are similar to those [2] creatinine – 3.8 mg/dl, angiotensin converting enzyme in elderly as in literature in studies by Usha et al. and [3] level – 64.25 U/L, and serum calcium – 13.3 mg/dl. Liver Bladé et al. The above case shows ditcher body inclusions function tests and serum electrolytes were normal and in plasma cells on bone marrow aspiration. HIV and HBsAg were nonreactive.
    [Show full text]
  • Successful Autologous Peripheral Blood Stem Cell Harvest and ­Transplantation After Splenectomy in a Patient with Multiple ­Myeloma with Hereditary Spherocytosis
    International Journal of Myeloma 8(3): 11–15, 2018 CASE REPORT ©Japanese Society of Myeloma Successful autologous peripheral blood stem cell harvest and transplantation after splenectomy in a patient with multiple myeloma with hereditary spherocytosis Daisuke FURUYA1,4, Rikio SUZUKI1,4, Jun AMAKI1, Daisuke OGIYA1, Hiromichi MURAYAMA1,2, Hidetsugu KAWAI1, Akifumi ICHIKI1,3, Sawako SHIRAIWA1, Shohei KAWAKAMI1, Kaito HARADA1, Yoshiaki OGAWA1, Hiroshi KAWADA1 and Kiyoshi ANDO1 Hereditary spherocytosis (HS) is the most common inherited red cell membrane disorder worldwide. We herein report a 58-year-old male HS patient with mild splenomegaly who developed symptomatic multiple myeloma (MM). Autologous stem cell transplantation (ASCT) was considered to be adopted against MM, although there was a possibility of splenic rupture following stem cell mobilization. Therefore, splenectomy was performed prior to stem cell harvest, and he was able to safely mobilize sufficient CD34+ cells with G-CSF and plerixafor and undergo ASCT. This case suggests that stem cell mobilization after splenectomy is safe and effective in HS patients complicated with malignancies. Key words: multiple myeloma, hereditary spherocytosis, splenectomy, autologous peripheral blood stem cell harvest Introduction Consolidation with melphalan-based HDT followed by ASCT is still the standard treatment option for transplant-eligible Multiple myeloma (MM) is characterized by clonal prolifera- patients with MM, leading to higher complete response rates tion of abnormal plasma cells in the bone marrow (BM) micro- and increased progression-free survival and overall survival environment, monoclonal protein in the blood and/or urine, compared with conventional chemotherapy regimens [2]. bone lesions, and immunodeficiency [1]. In recent years, the Importantly, the emergence of novel agent-based therapy introduction of high-dose chemotherapy (HDT) and autol- combined with ASCT has revolutionized MM therapy [2].
    [Show full text]
  • Clinical Hematology 1
    CLINICAL HEMATOLOGY 1 CLINICAL HEMATOLOGY Editor Gamal Abdul Hamid, MD,PhD Associate Professor Faculty of Medicine and Health Sciences University of Aden CLINICAL HEMATOLOGY 2 PREFACE Clinical Hematology, first edition is written specifically for medical students, the clinician and resident doctors in training and general practioner. It is a practical guide to the diagnosis and treatment of the most common disorders of red blood cells, white blood cells, hemostasis and blood transfusion medicine. Each disease state is discussed in terms of the pathophysiology, clinical and paraclinical features which support the diagnosis and differential diagnosis. We bring together facts, concepts, and protocols important for the practice of hematology. In addition this book is also supported with review questions and quizzes. G.A-H 2012 CLINICAL HEMATOLOGY 3 CONTENTS Preface 1. Hematopoiesis 7 2. Anemia 26 3. Iron Deficiency Anemia 32 4. Hemolytic Anemia 41 5. Sickle Cell Hemoglobinopathies 49 6. Thalassemia 57 7. Hereditary Hemolytic Anemia 63 8. Acquired Hemolytic Anemia 68 9. Macrocytic Anemia 75 10. Bone Marrow Failure, Panctopenia 87 11. Spleen 95 12. Acute Leukemia 99 13. Chronic Myeloproliferative Disorders 125 14. Chronic Lymphoproliferative Disorders 137 15. Malignant Lymphoma 147 16. Multiple Myeloma and Related Paraproteinemia 171 17. Hemorrhagic Diseases 179 18. Transfusion Medicine 201 19. Bone Marrow Transplantations 214 CLINICAL HEMATOLOGY 4 Appendices: I. Hematological Tests and Normal Values 221 II. CD Nomenclature for Leukocytes Antigen 226 III. Cytotoxic Drugs 228 IV. Drugs Used in Hematology 230 Glossary 232 Answers 246 Bibliography 247 CLINICAL HEMATOLOGY 5 CLINICAL HEMATOLOGY 6 HEMATOPOIESIS 1 All of the cells in the peripheral blood have finite life spans and thus must be renewed continuously.
    [Show full text]
  • © 2016 First Aid for the USMLE Step 1
    Index A Abscess, 442 vs. aspirin, in pediatric patients, 446 Achondroplasia, 426 Abacavir, 184 Absence seizures, 494 free radical injury and, 221 autosomal dominance of, 71 for HIV, 186 drug therapy for, 500 necrosis caused by, 252 chromosome associated with, 75 Abciximab, 214, 407 treatments for, 638 for osteoarthritis, 430 endochondral ossification in, 425 thrombogenesis and, 385 Absolute risk reduction (ARR), 34, for tension headaches, 494 AChR (acetylcholine receptor), 229 Abdominal aorta, 342 646 toxicity effects, 446 Acid-base physiology, 543 atherosclerosis in, 286, 645 Absorption disorders, anemia caused toxicity treatment for, 251 Acidemia, 543 bifurcation of, 609 by, 388 Acetazolamide, 254, 557 diuretic effect on, 558 498 92 Abdominal aortic aneurysm, 286 Abuse for glaucoma, Acidic amino acids, metabolic acidosis caused by, 543 Acidosis, 543 Abdominal colic confidentiality exceptions and, 41 in nephron physiology, 537 contractility in, 267 lead poisoning as cause, 389 dependent personality disorder for pseudotumor cerebri, 471 hyperkalemia caused by, 542 Abdominal distension and, 519 site of action, 556 Acid phosphatase, in neutrophils, 378 duodenal atresia as cause, 338 Acalculia, 464 Acetoacetate, metabolism of, 102 Acid reflux Abdominal pain Acamprosate Acetone breath, in diabetic esophageal strictures and, 354 Budd-Chiari syndrome as for alcoholism, 523, 638 ketoacidosis, 331 esophagitis and, 354 cause, 368, 630 diarrhea caused by, 252 Acetylation, 57 H blockers for, 374 cilostazol/dipyridamole as Acanthocytes, 386 2 Acetylcholine
    [Show full text]
  • Myeloma for Diagnosticians
    Myeloma for Diagnosticians Dr Mamta Garg Consultant Haematologist What is Myeloma? Malignant disorder of plasma cells • an excess of abnormal plasma cells >10% • paraprotein in the serum and/or urine • End organ affection CRAB, SLiM CRAB Diagnosis: Paraprotein or M protein SPEP CRAB and now “Slim CRAB” • Myeloma defining events or Evidence of end organ damage that can be attributed to the underlying plasma cell proliferative disorder, specifically: – C: Hypercalcaemia: serum calcium >0·25 mmol/L higher than the upper limit of normal or >2·75 mmol/L R: Renal insufficiency – R: Creatinine clearance <40 mL per min or serum creatinine >177 μmol/L (>2 mg/dL) – A: Anaemia: Hb >20 g/L below usual Hb, or a Hb <100 g/L – B: Bone lesions: one or more osteolytic lesions on XR, CT or PET-CT • Any one or more of the following biomarkers of malignancy: – S (M-spike) : Clonal bone marrow plasma cell percentage* ≥60% – Li: Involved:uninvolved serum free light chain ratio≥100 (or <0.01) – M: >1 focal lesions on MRI studies of 1 cm in size Rajkumar et al. Lancet Oncol. 2014 Nov;15(12):e538-48 Asymptomatic/Smouldering Myeloma • M protein present in serum and/or urine • Plasma cells >10% in the marrow • No CRABs • It carries a higher risk of progression to frank multiple myeloma (10% per year the first 5 years) compared with MGUS ISS, now Revised ISS or R-ISS LDH and FISH analysis on BM sample mandatory ISS STAGE CRITERIA RISK CRITERIA I B2M <3.5 Albumin >35 Normal Normal Serum LDH <upper limit of normal II B2M >3.5 but <5.5 or Albumin <35 High High serum
    [Show full text]
  • Open Full Page
    3IULTIPLE MYELOMA A REPORTOF FIVECASES ERNEST SCOTT, M.D., F. M. STANTON, M.D., AND MARY OLIVER, MA. (From the Department of Pathology, Ohio State University) In 1848 Sir Henry Bence-Jones aiid Sir James Watson pre- sented a paper entitled, “On a New substance Occurring in the Urine of a Patient with Mollitis-ossium,” a “substance” now known as the Bence-Jones bodies, frequeiitly found in the urine of patients with multiple myeloma. The clinical discussion of this same case mas presented in 1850 by McIntyre. In 1873 von Rustizky, in his histological studies of the disease, recognized its involvement of the bone marrow and gave it the name of multiple myeloma. IGililer, in 1889, ~lsopresented a clinical description of the disease and inasmuch as he, rather than McIntyre, has often been credited with the first clinical presentation, the term “Kahler ’s disease” is frequently encountered in the older litera- ture. In 1920 Wallgren reported 120 cases with histological verifica- tion. In 1928 Geschickter and Copeland (l), from the surgical pathological material of the Johns Hopkins Hospital, reported a series of 13 cases, together with a complete review of all available cases in the literature, making a total of 425 cases. Since the publication of this comprehensive article with its discussion of the clinical and structural characteristics of the disease, we have been able to collect from the more recent literature 30 cases of multiple myeloma. To these we add 5 cases from among about 4400 au- topsies in our own series. Grouped by years, the additional cases are : 1927 : Lewis (2), Meyeriling (3), Kleine (4) ; 1928: Battaglia (5), Hcilmann (6), Barr (7),Durman (8), Short iind Crawford (9) ; 1929: Hewitt (10) (5 cases), Stone (ll), Cappel1 (12) (2 cases), Rogers (13), Hub- bard and Case (14) ; 1930: Perla aiid Hutner (15) (2 cases), Cabot (16), Geschickter (17), Freund (18) ; 1931: Cabot (19), Porchownik (20), Jackson et a1 (21) (5 cases).
    [Show full text]
  • Pathology Course
    Pathology Course Kindly Sponsored by: Edited by: Michelle Kunc, Jhia Teh, Sally Barker and Yvonne Tsitsiou 1 Introduction The Medical Education Society (MedED) was established in 2004 by three students who were keen to develop schemes whereby senior students tutor younger ones - ‘peer-to- peer’ learning. It was decided that teaching would be outside the formal curriculum and the topics covered would reflect learning needs identified by members of the society and student body. This year we have coordinated PACES and Pathology revision courses, which are being delivered by past ICSM students. We hope you enjoy our Year 5 events and find their content useful for your revision. We would like to thank all the doctors involved in the production of this guide for their support and for taking time out of the schedules to come back and teach us. We would also like to thank the previous MedED guide editors: • 2016-2017: Daniel Campioni-Norman, Rhys Smith, Helen-Cara Younan and Rebekah Judge • 2017-2018: Charlie Caird, Stephanie EzeKwe, Mohammad Fallaha, Samyukta Sundar • 2018-2019: Sophia von Widekind, Lasith Ranasinghe, Daniel Huddart, Alex Huddart If you have any questions please contact us at [email protected]. Please note: MedED does not represent the ICSM Faculty or Student Union. This guide has been produced by students and the Pathology Course lecturers. We have made every effort to ensure that the following information is accurate and reliable. However, this guide should not be used to replace formal ICSM teaching and education
    [Show full text]
  • View the 2019 Index
    Index A Abnormal uterine bleeding (AUB), heart failure, 311 Achondroplasia, 454 A-a gradient 618, 619 hypertension, 319 chromosome disorder, 64 in elderly, 654 adenomyosis, 634 naming convention for, 253 endochondral ossification in, 450 with hypoxemia, 654, 655 anemia with, 410 preload/afterload effects, 282 inheritance, 60 restrictive lung disease, 661 Asherman syndrome, 634 teratogenicity, 600 AChR (acetylcholine receptor), 229 Abacavir, 201, 203 leiomyoma (fibroid), 634 Acetaldehyde, 72 Acid-base physiology, 580 Abciximab, 122 polyps (endometrial), 634 Acetaldehyde dehydrogenase, 70, 72 Acidemia, 580 Glycoprotein IIb/IIIa inhibitors, thecoma, 632 Acetaminophen, 474 diuretic effect on, 595 429 ABO blood classification, 397 vs. aspirin for pediatric patients, 474 Acid-fast oocysts, 177 thrombogenesis and, 403 newborn hemolysis, 397 free radical injury and, 210 Acid-fast organisms, 125, 140, 155 Abdominal aorta, 357 Abruptio placentae, 626 hepatic necrosis from, 249 Acidic amino acids, 81 atherosclerosis in, 305, 687 cocaine use, 600 N-acetylcysteine for overdose, 671 Acid maltase, 86 bifurcation of, 649 preeclampsia, 629 for osteoarthritis, 458 Acidosis, 578, 580 Abdominal aortic aneurysm, 306 Abscess, 470 toxicity effects, 474 contractility in, 282 Abdominal colic acute inflammation and, 215 toxicity treatment for, 247 hyperkalemia with, 578 lead poisoning, 411 lung, 670 Acetazolamide, 252, 539, 594 Acid phosphatase in neutrophils, 398 Abdominal pain Absence seizures idiopathic intracranial Acid reflux bacterial peritonitis, 384 characteristics
    [Show full text]